comparemela.com

Latest Breaking News On - Merger assessment guidelines - Page 3 : comparemela.com

CMA publishes environmental sustainability advice to government

CMA publishes environmental sustainability advice to government
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Digital markets essential role must operate effectively

An interview with White & Case LLP discussing Merger Control in United Kingdom

Antitrust Merger Control Joint Statement: UK, Germany, Australia

Tuesday, May 11, 2021 On 20 April 2021, the UK’s Competition and Markets Authority (CMA), the German Bundeskartellamt (BKartA) and the Australian Competition and Consumer Commission (ACCC) issued a joint statement¹ and held a joint online event pushing for more rigorous merger control enforcement. Our global competition team in these jurisdictions unpacks the joint statement and provides the following insights. Main takeaways The main takeaway for businesses is to be prepared for more intervention in deals, especially deals involving dynamic and fast-paced markets, such as digital markets and life sciences. In particular, businesses should expect closer scrutiny – and skepticism – of statements about the benefits of a deal, with the consequent need to rebut with hard evidence a “

GT Newsletter | Competition Currents | February 2021 | Insights

In this Issue: United States 1. FTC to study impact of physician group and health care facility mergers. As part of its Merger Retrospective Program, on Jan. 13, 2021, the FTC issued an Order to File a Special Report to six health insurance companies. The FTC plans to use information gathered through the Special Report (e.g., patient-level data from 2015 to 2020) to analyze the competitive impact of physician and health care facility consolidation, as well as mergers and acquisitions, in markets for health care services. 2. FTC approves final order imposing conditions on combination of Pfizer Inc.’s Upjohn and Mylan N.V. On Jan. 28, 2021, the FTC announced its final order approving the combination of the Upjohn division of Pfizer Inc. and Mylan N.V. in a spinoff, forming Viatris Inc. The FTC alleged that the proposed acquisition would harm competition in generic drug markets. The final order requires the parties to divest certain rights and assets in seven current generic

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.